Biologics and Small Molecules in Lichen Sclerosus: A Systematic Review
Published: 7 October 2024| Version 1 | DOI: 10.17632/6kvm94v2bs.1
Contributor:
Hibo RijalDescription
Lichen sclerosus (LS) is a chronic inflammatory disease characterized by hypopigmentation and skin atrophy, with often poor response to initial conventional corticosteroid therapy. This review evaluates outcomes of biologic and Janus Kinase inhibitor (JAK) therapy in LS.
Files
Institutions
Queen's University
Categories
Dermatology